Cargando…
Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in Apc(Min/+) mice
Cancer cachexia is a complex wasting condition characterized by chronic inflammation, disrupted energy metabolism, and severe muscle wasting. While evidence in pre-clinical cancer cachexia models have determined that different systemic inflammatory inhibitors can attenuate several characteristics of...
Autores principales: | Narsale, Aditi A., Puppa, Melissa J., Hardee, Justin P., VanderVeen, Brandon N., Enos, Reilly T., Murphy, E. Angela, Carson, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312326/ https://www.ncbi.nlm.nih.gov/pubmed/27449092 http://dx.doi.org/10.18632/oncotarget.10699 |
Ejemplares similares
-
Liver Inflammation and Metabolic Signaling in Apc(Min/+) Mice: The Role of Cachexia Progression
por: Narsale, Aditi A., et al.
Publicado: (2015) -
Characterization of the male Apc(Min/+) mouse as a hypogonadism model related to cancer cachexia
por: White, James P., et al.
Publicado: (2013) -
Platelet status in cancer cachexia progression in Apc(Min/+) mice
por: Cunningham, Patrice, et al.
Publicado: (2023) -
The effect of exercise on IL-6-induced cachexia in the Apc(Min/+) mouse
por: Puppa, Melissa J., et al.
Publicado: (2011) -
Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis
por: Miao, Chunxiao, et al.
Publicado: (2017)